BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mikulak J, Oriolo F, Portale F, Tentorio P, Lan X, Saleem MA, Skorecki K, Singhal PC, Mavilio D. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes. Retrovirology 2016;13:63. [PMID: 27599995 DOI: 10.1186/s12977-016-0296-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Freedman BI, Kistler AL, Skewes-Cox P, Ganem D, Spainhour M, Turner J, Divers J, Langefeld CD, Murea M, Hicks PJ, Hemal AK, Snipes JA, Zhao L, Abend JR, Lyles DS, Ma L, Skorecki KL. JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans. Nephrol Dial Transplant 2018;33:1960-7. [PMID: 29420808 DOI: 10.1093/ndt/gfx368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
2 Kumar V, Ayasolla K, Jha A, Mishra A, Vashistha H, Lan X, Qayyum M, Chinnapaka S, Purohit R, Mikulak J, Saleem MA, Malhotra A, Skorecki K, Singhal PC. Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu. Am J Physiol Cell Physiol 2019;317:C209-25. [PMID: 31116585 DOI: 10.1152/ajpcell.00538.2018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
3 Tedla FM, Yap E. Apolipoprotein L1 and kidney transplantation. Curr Opin Organ Transplant 2019;24:97-102. [PMID: 30507707 DOI: 10.1097/MOT.0000000000000600] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Araújo SA, Cordeiro TME, Belisário AR, Araújo RFA, Marinho PES, Kroon EG, de Oliveira DB, Teixeira MM, Simões E Silva AC. First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection. Clin Kidney J 2019;12:355-61. [PMID: 31198534 DOI: 10.1093/ckj/sfy104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Kruzel-Davila E, Skorecki K. Dilemmas and challenges in apolipoprotein L1 nephropathy research. Curr Opin Nephrol Hypertens 2019;28:77-86. [PMID: 30431460 DOI: 10.1097/MNH.0000000000000462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Scales SJ, Gupta N, De Mazière AM, Posthuma G, Chiu CP, Pierce AA, Hötzel K, Tao J, Foreman O, Koukos G, Oltrabella F, Klumperman J, Lin W, Peterson AS. Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes. J Am Soc Nephrol 2020;31:2044-64. [PMID: 32764142 DOI: 10.1681/ASN.2019080829] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
7 Wen H, Kumar V, Lan X, Shoshtari SSM, Eng JM, Zhou X, Wang F, Wang H, Skorecki K, Xing G, Wu G, Luo H, Malhotra A, Singhal PC. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress. Biosci Rep 2018;38:BSR20171713. [PMID: 29967295 DOI: 10.1042/BSR20171713] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
8 Jotwani V, Atta MG, Estrella MM. Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy. J Am Soc Nephrol 2017;28:3142-54. [PMID: 28784698 DOI: 10.1681/ASN.2017040468] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
9 Kumar V, Paliwal N, Ayasolla K, Vashistha H, Jha A, Chandel N, Chowdhary S, Saleem MA, Malhotra A, Chander PN, Skorecki K, Singhal PC. Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton. Sci Rep 2019;9:3582. [PMID: 30837512 DOI: 10.1038/s41598-019-39376-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
10 Kaur S U, Oyeyemi BF, Shet A, Gopalan BP, D H, Bhavesh NS, Tandon R. Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy. PLoS One 2020;15:e0238316. [PMID: 32866201 DOI: 10.1371/journal.pone.0238316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Divers J, Langefeld CD, Lyles DS, Ma L, Freedman BI. Protective association between JC polyoma viruria and kidney disease. Curr Opin Nephrol Hypertens 2019;28:65-9. [PMID: 30320619 DOI: 10.1097/MNH.0000000000000464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 An P, Kirk GD, Limou S, Binns-Roemer E, Kopp JB, Winkler CA. Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression. Front Immunol 2019;10:53. [PMID: 30733721 DOI: 10.3389/fimmu.2019.00053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Mishra A, Ayasolla K, Kumar V, Lan X, Vashistha H, Aslam R, Hussain A, Chowdhary S, Marashi Shoshtari S, Paliwal N, Popik W, Saleem MA, Malhotra A, Meggs LG, Skorecki K, Singhal PC. Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu. Am J Physiol Renal Physiol 2018;314:F832-43. [PMID: 29357419 DOI: 10.1152/ajprenal.00541.2017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
14 Kopp JB, Heymann J, Winkler CA. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy. Semin Nephrol 2017;37:514-9. [PMID: 29110758 DOI: 10.1016/j.semnephrol.2017.07.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
15 Goyal R, Singhal PC. APOL1 risk variants and the development of HIV-associated nephropathy. FEBS J 2021;288:5586-97. [PMID: 33340240 DOI: 10.1111/febs.15677] [Reference Citation Analysis]
16 Kruzel-Davila E, Sankofi BM, Kubi Amos-Abanyie E, Ghansah A, Nyarko A, Agyemang S, Awandare GA, Szwarcwort-Cohen M, Reiner-Benaim A, Hijazi B, Ulasi I, Raji YR, Boima V, Osafo C, May Adabayeri V, Matekole M, Olanrewaju TO, Ajayi S, Mamven M, Antwi S, Ademola AD, Plange-Rhule J, Arogundade F, Akyaw PA, Winkler CA, Salako BL, Ojo A, Skorecki K, Adu D. HIV Viremia Is Associated With APOL1 Variants and Reduced JC-Viruria. Front Med (Lausanne) 2021;8:718300. [PMID: 34513880 DOI: 10.3389/fmed.2021.718300] [Reference Citation Analysis]
17 Valsecchi M, Cazzetta V, Oriolo F, Lan X, Piazza R, Saleem MA, Singhal PC, Mavilio D, Mikulak J, Aureli M. APOL1 polymorphism modulates sphingolipid profile of human podocytes. Glycoconj J 2020;37:729-44. [PMID: 32915357 DOI: 10.1007/s10719-020-09944-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Bruggeman LA. Common Mechanisms of Viral Injury to the Kidney. Adv Chronic Kidney Dis 2019;26:164-70. [PMID: 31202388 DOI: 10.1053/j.ackd.2018.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
19 Uzureau S, Lecordier L, Uzureau P, Hennig D, Graversen JH, Homblé F, Mfutu PE, Oliveira Arcolino F, Ramos AR, La Rovere RM, Luyten T, Vermeersch M, Tebabi P, Dieu M, Cuypers B, Deborggraeve S, Rabant M, Legendre C, Moestrup SK, Levtchenko E, Bultynck G, Erneux C, Pérez-Morga D, Pays E. APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin. Cell Rep 2020;30:3821-3836.e13. [PMID: 32187552 DOI: 10.1016/j.celrep.2020.02.064] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 22.0] [Reference Citation Analysis]
20 Kumar V, Singhal PC. APOL1 and kidney cell function. Am J Physiol Renal Physiol 2019;317:F463-77. [PMID: 31241995 DOI: 10.1152/ajprenal.00233.2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
21 Chaudhary NS, Moore JX, Zakai NA, Judd SE, Naik RP, Limou S, Cushman M, Lange LA, Wang HE, Winkler CA, Irvin MR, Kopp JB, Gutiérrez OM. APOL1 Nephropathy Risk Alleles and Risk of Sepsis in Blacks. Clin J Am Soc Nephrol 2019;14:1733-40. [PMID: 31704668 DOI: 10.2215/CJN.04490419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Bruggeman LA, O'Toole JF, Sedor JR. APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function? Am J Physiol Renal Physiol 2019;316:F1-8. [PMID: 30332315 DOI: 10.1152/ajprenal.00426.2018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
23 Kumar V, Vashistha H, Lan X, Chandel N, Ayasolla K, Shoshtari SSM, Aslam R, Paliwal N, Abbruscato F, Mikulak J, Popik W, Atta MG, Chander PN, Malhotra A, Meyer-Schwesinger C, Skorecki K, Singhal PC. Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition. Am J Pathol 2018;188:2508-28. [PMID: 30201495 DOI: 10.1016/j.ajpath.2018.07.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
24 Beckerman P, Susztak K. APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease. Trends Mol Med 2018;24:682-95. [PMID: 29886044 DOI: 10.1016/j.molmed.2018.05.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]